Dinesh M. Kumar - Sep 5, 2025 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Chief Medical Officer
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Stock symbol
ASTH
Transactions as of
Sep 5, 2025
Transactions value $
-$50,312
Form type
4
Date filed
9/9/2025, 04:35 PM
Previous filing
Jul 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kumar Dinesh M. Chief Medical Officer C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA /s/ Kathy Diep, as Attorney-in-Fact 2025-09-09 0001850439

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Tax liability -$50.3K -1.69K -0.77% $29.70 218K Sep 5, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025.
F2 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 13,464 shares, which will vest on January 1, 2026; and (iii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
F3 Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.